Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Waldemar Priebe Insider Profile
4 Followers
Waldemar Priebe, Ten Percent Owner at Moleculin Biotech, holds ― shares in Moleculin Biotech (Ticker: MBRX), holds 156.81K shares in CNS Pharmaceuticals (Ticker: CNSP). Most recently, Waldemar Priebe ― shares of Moleculin Biotech on ― for an estimated value of ―.
Waldemar Priebe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Waldemar Priebe holds in companies
Most Profitable Insider Trade
The most profitable trade made by Waldemar Priebe
Waldemar Priebe's Trading History
Moleculin Biotech
―
Ten Percent Owner
―
―
CNS Pharmaceuticals
Aug 01, 2023
Ten Percent Owner
Informative Sell
133.11K
$169.35K
List of latest transactions for each holding click on a transaction to see Waldemar Priebe's performance on stock
You May Also Like
Waldemar Priebe insider profile FAQ
What is the percentage of profitable transactions made by Waldemar Priebe?
The percentage of profitable transactions made by Waldemar Priebe is ―.
What is the average return per transaction made by Waldemar Priebe?
The average return per transaction made by Waldemar Priebe is ―.
What stocks does Waldemar Priebe hold?
Waldemar Priebe holds: MBRX, CNSP stocks.
What was Waldemar Priebe’s latest transaction?
Waldemar Priebe latest transaction was an Uninformative Buy of ―.
What was Waldemar Priebe's most profitable transaction?
Waldemar Priebe’s most profitable transaction was an Informative Sell of CNSP stock on August 1, 2023. The return on the trade was 99.00%.
What is Waldemar Priebe's role in Moleculin Biotech?
Waldemar Priebe's role in Moleculin Biotech is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.